Content about Johns Hopkins University

November 7, 2012
Study: Liquor costs more at state-owned stores than in private stores

Liquor can cost $2 more at liquor stores in states where the government has a monopoly on sales than at privately owned stores, according to a new study.

NEW YORK — Liquor can cost $2 more at liquor stores in states where the government has a monopoly on sales than at privately owned stores, according to a new study.

Researchers at Boston University School of Public Health, the Boston Medical Center and Johns Hopkins University analyzed the prices of 74 different alcohol brands in 13 "control states" — states where the government has a monopoly on liquor sales — and at 50 private retailers in "license states." The study appeared online in the journal Addiction.

November 15, 2011
Hearing loss more prevalent than previously thought

Nearly one-fifth of all Americans ages 12 years and older have hearing loss so severe that it may make communication difficult, according to a new study led by Johns Hopkins researchers and published in the Nov. 14 issue of the Archives of Internal Medicine.

BALTIMORE — Nearly one-fifth of all Americans ages 12 years and older have hearing loss so severe that it may make communication difficult, according to a new study led by Johns Hopkins researchers and published in the Nov. 14 issue of the Archives of Internal Medicine. The findings, thought to be the first nationally representative estimate of hearing loss, suggest that many more people than previously thought are affected by this condition.

May 25, 2011
Walgreens, Johns Hopkins Medicine announce chronic disease research collaboration

Johns Hopkins Medicine and Walgreens on Wednesday announced an agreement between the two companies that will promote collaboration on population-based research.

CHICAGO — Johns Hopkins Medicine and Walgreens on Wednesday announced an agreement between the two companies that will promote collaboration on population-based research.

Also part of the agreement, Johns Hopkins and Walgreens will jointly review and develop protocols to improve outcomes of patients with chronic diseases and explore the development of new models for improving care for individuals.

March 18, 2011
Journal notes heart-related risks posed by Avandia

With respect to the Type 2 diabetes drug Avandia, British drug maker GlaxoSmithKline has another medical study to worry about.

LONDON — With respect to the Type 2 diabetes drug Avandia, British drug maker GlaxoSmithKline has another medical study to worry about.

March 15, 2011
Study: Metformin best first-line diabetes treatment

While several drugs to treat Type 2 diabetes are on the market, researchers have found that the best first-line option is metformin.

NEW YORK — While several drugs to treat Type 2 diabetes are on the market, researchers have found that the best first-line option is metformin.

Led by Wendy Bennett, an assistant professor of medicine at Johns Hopkins University School of Medicine in Baltimore, researchers reviewed 140 trials and 26 observational studies of head-to-head comparisons of monotherapy or combination therapy that reported intermediate or long-term clinical outcomes or harms of six oral diabetes medications.

March 4, 2011
Study: Potassium levels may be insight to racial disparity among diabetics

Researchers at Johns Hopkins University School of Medicine have discovered that potassium levels in the blood may explain a racial disparity among Type 2 diabetes patients.

NEW YORK — Researchers at Johns Hopkins University School of Medicine have discovered that potassium levels in the blood may explain a racial disparity among Type 2 diabetes patients.

According to a new study published in the American Journal of Clinical Nutrition, among 12,000 participants, more than 2,000 African-Americans in the study had lower average serum potassium levels than the more than 9,000 whites in the study. They also were twice as likely to develop Type 2 diabetes.